
Telitacicept: A New Therapy for the Treatment of Optic Neuromyelitis Spectrum Disease Associated with Other Autoimmune ...
Introduction Neuromyelitis optica spectrum disorders (NMOSD) constitute a group of autoimmune-mediated, inflammatory demyelinating diseases affecting the central nervous system (CNS), predominantly involving the optic nerves and spinal cord.1,2 The …